Skip to main content
SpringerLink
Log in

Is oral anticoagulation plus antiplatelet therapy superior to oral anticoagulation alone in patients with atrial fibrillation and stable coronary artery disease?

  • Commentary
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sonia S, Anand SS, Yusuf S. Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol. 2003;41:62S-69S.

    Article  Google Scholar 

  2. Lopes RD, Heiser G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, et al. for the AUGUSTUS Investigators Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med. 2019;380:1509–24.

    Article  CAS  PubMed  Google Scholar 

  3. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213–60.

    Article  PubMed  Google Scholar 

  4. Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H, et al. Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond one year after coronary stent implantation. Circulation. 2019;139:604–16.

    Article  CAS  PubMed  Google Scholar 

  5. Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, for the AFIRE investigators. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Eng J Med. 2019;381:1103–13.

    Article  CAS  Google Scholar 

  6. Naito R, Miyauchi K, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H, for the AFIRE Investigators. Rivaroxaban monotherapy vs combination therapy with antiplatelets on total thrombotic and bleeding events in atrial fibrillation with stable coronary artery disease: a post hoc secondary analysis of the AFIRE trial JAMA Cardiol. 2022;1(7):787–94.

    Google Scholar 

  7. Shakir A Khan A Agarwal S Clifton S, Reese J Munir MB Nasir UB Khan SU Gopinathannair R DeSimone CV Deshmukh A Jackman WM Stavrakis S Asad ZUA. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2022. https://doi.org/10.1007/s10840-022-01347-1.

Download references

Author information

Authors and Affiliations

  1. Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA

    Virginia Laura Gonzalez

  2. Division of Electrophysiology, Heart and Vascular Institute, Penn State Health Milton S. Hershey Medical Center, Penn State University School of Medicine, Hershey, PA, USA

    Mario Daniel Gonzalez

Authors
  1. Virginia Laura Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Daniel Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mario Daniel Gonzalez.

Ethics declarations

Ethics approval

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s10840-022-01347-1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gonzalez, V.L., Gonzalez, M.D. Is oral anticoagulation plus antiplatelet therapy superior to oral anticoagulation alone in patients with atrial fibrillation and stable coronary artery disease?. J Interv Card Electrophysiol 66, 1031–1032 (2023). https://doi.org/10.1007/s10840-022-01379-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01379-7

Search

Navigation